The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood / Massimino, M., Biassoni, V., Miceli, R., Schiavello, E., Warmuth-Metz, M., Modena, P., Casanova, M., Pecori, E., Giangaspero, F., Antonelli, M., Buttarelli, F.R., Potepan, P., Pollo, B., Nunziata, R., Spreafico, F., Podda, M., Anichini, A., Clerici, C.A., Sardi, I., De Cecco, L., et al.. - In: JOURNAL OF NEURO-ONCOLOGY. - ISSN 0167-594X. - 138:3(2018), pp. 679-680. [10.1007/s11060-018-2893-6]
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
Giangaspero, FeliceInvestigation
;Antonelli, ManilaInvestigation
;Buttarelli, Francesca Romana;
2018
Abstract
The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).| File | Dimensione | Formato | |
|---|---|---|---|
|
Massimino_Correction-to-Results_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
512.68 kB
Formato
Adobe PDF
|
512.68 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
